CODX: Co-Diagnostics, Inc. - Summary | Jitta

Co-Diagnostics, Inc.

NASDAQ:CODX

Price
$9.86
Loss Chance
47.1%
3.25JITTA SCORE
14.25%Over Jitta Line
Jitta Ranking
71 / 1,042
1,104 / 4,597
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (54)
Recent Business Performance (72)
Financial Strength (50)
Return to Shareholders (22)
Competitive Advantage (57)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
3.25
14.25%
2.24
353.92%
Health Care Equipment
7.22
80.79%
5.25
30.35%
7.64
361.01%
COMPANY DESCRIPTION
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.